To: | Teva Pharmaceutical Industries Limited (trademarks.trademarks@tevapharm.com) |
Subject: | U.S. Trademark Application Serial No. 88749354 - TEVA - N/A |
Sent: | January 29, 2020 11:06:36 AM |
Sent As: | ecom128@uspto.gov |
Attachments: |
United States Patent and Trademark Office (USPTO)
Office Action (Official Letter) About Applicant’s Trademark Application
U.S. Application Serial No. 88749354
Mark: TEVA
|
|
Correspondence Address: |
|
Applicant: Teva Pharmaceutical Industries Limited
|
|
Reference/Docket No. N/A
Correspondence Email Address: |
|
EXAMINER’S AMENDMENT
Issue date: January 29, 2020
USPTO database searched; no conflicting marks found. The trademark examining attorney searched the USPTO database of registered and pending marks and found no conflicting marks that would bar registration under Trademark Act Section 2(d). 15 U.S.C. §1052(d); TMEP §704.02.
Application has been amended as shown below. As agreed to by Larry Rickles, applicant’s attorney on 1/28/2020, the examining attorney has amended the application as shown below. Please notify the examining attorney immediately of any objections. TMEP §707.
MARK DESCRIPTION
The following description of the mark replaces the current description of record:
“The mark consists of THE WORD "TEVA" IN LOWER CASE DARK BLUE LETTERS WITH THE "V" IN THE SHAPE OF TWO LEAVES.”
See 37 C.F.R. §§2.37, 2.72; TMEP §§808 et seq.
TRANSLATION STATEMENT
The following translation statement is added to the record:
The English translation of the word “TEVA” in the mark is “NATURE”.
See 37 C.F.R. §§2.32(a)(9), 2.61(b); TMEP §§809, 809.03.
DOMICILE STREET ADDRESS
Applicant has indicated its current domicile as the following physical U.S. street address:
Science Based Industries Campus, Har Hotzvim, Jerusalem 91010, Israel
See 37 C.F.R. §2.189.
Hansrajh, Keton
/Keton Hansrajh/
Trademark Examining Attorney
Law Office 128
(571) 272-3396
keton.hansrajh@uspto.gov